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Abstract  
Human mesenchymal stem cells (hMSCs) are a key candidate for advanced cell therapies with 
numerous clinical trials investigating their potential to treat acute and chronic indications. 
However, important translational and manufacturing challenges need to be addressed to improve 
our capability for scalable production of fully functional cells. In this study, we have demonstrated, 
both qualitatively and quantitatively, the ability of bone marrow-derived hMSCs to migrate from 
one microcarrier to another, and, to populate fresh microcarriers when added into suspension 
culture. Additionally, we have shown that compared to inoculating a culture with cells in free 
suspension, inoculating 10% of near-confluent microcarriers from an initial seed microcarrier 
culture resulted in an increase in the cell growth rate and overall cell yield and a significant 
reduction in the lag phase. These findings were consistent across cells from three different BM-
hMSC donors and across different culture medium conditions, foetal bovine serum-supplemented 
medium, human platelet lysate-supplemented medium and serum-free medium. This new cells-
on-beads inoculation method is an effective means of process intensification with the potential to 
decrease manufacturing times and potentially costs of hMSC-based therapies.  
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1. Introduction 
Advanced therapies, including cell and gene-based therapies, will form the next generation of 
therapeutics which have the potential to address unmet clinical need, treat chronic conditions and 
offer potential cures rather than simply alleviating patient symptoms (Barry and Murphy 2013). 
Adherent, or anchorage-dependent cells, are likely to be promising candidates for both 
autologous (patient-specific) and allogeneic (universal donor) cell-based therapies; such cells 
include human adult mesenchymal stem cells (hMSCs), human embryonic stem cells (hESCs) 
and human induced pluripotent stem cells (hiPSCs). However, the growth of adherent cells 
presents additional challenges in comparison to suspension cell platforms, and has therefore 
been the subject of considerable research activity (Rafiq 2016). Initially in the 1980s and 1990s, 
significant effort was directed at the production of adherent Chinese Hamster Ovary (CHO) cells 
for protein/vaccine production, and more recently, for the production of adherent stem cells for 
cell therapy applications. Established techniques for the growth of these cells involve monolayer 
culture, predominantly in tissue-culture flasks or roller bottles. However, as was recognised for 
adherent CHO cells in the 1980s, alternative manufacturing processes for the production of 
adherent cells are required which are scalable, robust, reproducible and cost-effective. This is 
achieved through the use of microcarriers in stirred-tank bioreactor systems and have been used 
for multiple cell types including CHO (Ohlson et al. 1994), hMSCs (Dos Santos et al. 2011; Rafiq 
et al. 2013a), hESCs (Chen et al. 2010) and hiPSCs (Badenes et al. 2017; Bardy et al. 2013). 
 
In monolayer culture, cell growth is maintained by keeping the cells in the log phase of the culture 
and is based upon ‘confluency’, the proportion of adherent cells covering the attachment surface. 
When cells reach an appropriate confluency level (usually 80% but can differ based on cell type), 
the cells are removed from the surface and plated into new tissue culture flasks in order to keep 
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them in the exponential phase, a process known as passaging. The process of passaging 
typically requires the use of a proteolytic enzyme such as trypsin, dispase or collagenase 
(Lindner et al. 1987) in conjunction with a chelating agent such as EDTA. The exposure of 
adherent cells to these reagents in the absence of serum-containing medium enables the 
digestion and cleaving of cell attachment proteins. However, frequent exposure to such reagents 
has been demonstrated to have adverse effects on mammalian cells including proteome 
alteration (Huang et al. 2010) and effects on cell shape and chromatin structure (Kapiszewska et 
al. 1991). As such there is concern regarding the consecutive passaging of cells, in part due to 
the long-term deleterious effects of dissociation reagents on the cell cytoskeleton (Madeira et al. 
2012). Although enzyme-free dissociation buffers also exist, some formulations may not be 
suitable for use with hMSCs. For example, a study using a Gibco-brand enzyme-free dissociation 
buffer to detach hMSCs grown on tissue culture plastic found that not only was cell viability 
following detachment significantly reduced compared to trypsin controls (~ 70% compared to > 
90%, respectively) but cells also failed to reattach to tissue culture plastic (Heng et al. 2009). 
 
Until now, hMSC microcarrier culture has followed the same approach as monolayer culture with 
respect to harvesting when cells reach confluency, i.e. the use of enzymes to detach cells from 
the surface of the microcarriers, preferably aided by agitation to reduce the time the cells are 
exposed to that environment (Nienow et al. 2014). However, unlike monolayer culture which is 
limited by the surface area available in the tissue culture flask, microcarrier/bioreactor culture has 
a significant advantage with respect to surface area to volume ratio and there is potential for the 
provision of additional microcarriers during a culture process when the cells are nearing 
confluency in order to maintain cell growth in the exponential phase for longer. For example, 
Hervy and colleagues recently maintained hMSCs on microcarriers for over 40 days using this 
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approach (Hervy et al. 2014). This extended culture time relies on the transfer of cells from one 
microcarrier/bead to another (called here for convenience, bead-to-bead transfer). Bead-to-bead 
transfer (or cell migration from one microcarrier to another) during suspension culture of adherent 
cells is believed to be a key mechanism for rapid and efficient cell expansion in suspension 
cultures (de Soure et al. 2016). This cell behaviour is of particular interest from a process 
development and manufacturing perspective as the demonstration of bead-to-bead transfer would 
facilitate the large-scale manufacture of stem cells via seed bioreactor cultures without the need 
to expose the cells to frequent deleterious proteolytic enzymes. This approach also facilitates 
process intensification by providing additional surface throughout the course of the culture, 
maintaining the cells in the exponential phase of growth for a longer period of time, thereby 
increasing yield and efficiency whilst reducing process costs and time. 
 
Although investigated and proven for adherent CHO and Vero cells (Ohlson et al. 1994; Wang 
and Ouyang 1999), work demonstrating such a phenomenon for hMSCs has to date focused on 
single hMSC donors (Takahashi et al. 2017), or an immortalised cell line (hMSC-TERT) (Leber et 
al. 2017) or it included complex agitation regimes (Hervy et al. 2014). In this study, we 
demonstrate, both qualitatively and quantitatively, the phenomenon of bead-to-bead transfer for 
three donor BM-hMSCs on different microcarriers (Plastic P102-L, Cytodex-3 and Hillex) in 
different culture medium conditions, foetal bovine serum (FBS), human platelet lysate (HPL) and 
serum-free medium (SFM). We also explore the use of a cells-on-beads inoculation procedure, 
which subsequently utilises bead-to-bead transfer (henceforth called ‘cells-on-beads inoculation’), 
in contrast to the standard free suspension inoculation procedure to facilitate process 
intensification. Several important parameters were measured throughout the culture including cell 
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growth kinetics, viability, key metabolite consumption and production, immune-phenotype and 
differentiation potential.  
2. Materials and methods 
2.1 hMSC monolayer expansion 
Human MSCs from three donors were used in this study. All were isolated from bone-marrow 
aspirate and obtained from Lonza (Walkersville, USA) after the donors provided informed 
consent. The university’s local Ethical Committee approved the use of the samples for research. 
The isolation and culture of primary hMSCs is described in Rafiq et al. (2013b); in brief, hMSCs 
were isolated on the basis of plastic adherence and cryopreserved at passage 1 at a density of 2 
x 106 cells/mL in 10 % dimethyl sulphoxide (DMSO) (v/v) (Sigma Aldrich, UK) and 90 % foetal 
bovine serum (FBS; Hyclone, Lot# RUF35869). The cells were cultured according to previously 
determined protocols (Rafiq et al., 2013; Heathman et. al., 2015). Briefly, the cells were seeded at 
5,000 cells/cm2 and grown on tissue culture plastic in DMEM (1 g/L glucose, Lonza, UK) 
supplemented with 10% (v/v) foetal bovine serum (FBS; HyClone) or 10% (v/v) non-heparin 
requiring (PL-NH) Stemulate™ (Cook Regentec, USA) for the human platelet lysate based culture 
conditions, and 2 mM UltraGlutamine (Lonza, UK).  
 
Where cells were also cultured under serum-free medium (SFM) conditions, the Prime-XVTM SFM 
hMSC medium was used (Irvine Scientific, USA) in accordance with the manufacturer’s 
instructions. As required, attachment surfaces were pre-coated with recombinant fibronectin 
(Irvine Scientific, USA). For both the SFM and HPL cultures, the BM-hMSCs underwent one 
adaptation passage in medium containing either the Prime-XVTM medium or 10% (v/v) PL-NH 
Stemulate™.  
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 2.2 Spinner flask microcarrier culture 
The spinner flask cultures involved the use of 100 mL BellCo spinner flasks (BellCo, USA), with a 
100 mL working volume and a vessel diameter (T) of 60 mm.  The spinner flask vessels were 
siliconized prior to use with Sigmacote (Sigma Aldrich, UK) as described in (Rafiq et al. 2016). 
The spinner flasks were agitated by a magnetic stirrer bar at the just suspended speed (NJS) 
placed on the Bell-EnniumTM Compact 5 position magnetic stirrer platform (BellCo, USA) with air 
in the headspace for surface aeration giving essentially 100% dO2. The microcarriers were 
prepared according to the manufacturer’s instructions and sterilised by autoclaving at 121ºC and 
1 atm for 15 minutes. Prior to use, the microcarriers were conditioned in growth medium for at 
least 1 hour to facilitate cell attachment. The surface area provided per spinner flask was 500 cm2 
and the cells were inoculated at a density of 6,000 cells/cm2 as previously described (Rafiq et. al., 
2013; Heathman et. al., 2015). This inoculation method, referred to later as the ‘control’, is in 
contrast to the ‘cells-on-beads’ inoculation method (discussed later in the results section) which 
involved inoculating 10% of near-confluent microcarriers from an initial seed microcarrier culture. 
In all cases, a 50% medium exchange was performed at 72 h in culture and then every 48 h 
thereafter.  
 
2.3 Analytical Techniques 
Cell counts and viability (via acridine orange uptake and DAPI exclusion) were determined using 
the Nucleocounter NC-3000 (Chemometec, UK). Cell viability was also assessed by the 
Live/Dead Viability/Cytotoxicity kit (Calcein AM/ Ethidium Homodimer; Life Sciences, 
ThermoFisher, UK) following the manufacturer’s instructions. Briefly, the cells were first washed 
with PBS and then incubated with the Live/Dead stain containing a final concentration of 2 µM 
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calcein-AM and 4 µM ethidium homodimer in the dark at 37ºC and 5% CO2 for 40 minutes. Post 
incubation, the Live/Dead working solution was removed and replaced with PBS. Samples were 
then visualised on a Nikon Ti Eclipse epi-fluorescence microscope (Nikon, UK).  
  
Analysis of glucose and lactate concentrations in the spent medium was performed using a 
Cedex Bio-HT (Roche, Germany). The following parameters were calculated from the data 
obtained: 
1. Specific Growth Rate 
𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆 𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔ℎ 𝑔𝑔𝑟𝑟𝑔𝑔𝑆𝑆, µ =  ln⎝⎜⎛𝐶𝐶𝑥𝑥(𝑡𝑡) 𝐶𝐶𝑥𝑥(0)� ⎠⎟⎞
∆𝑡𝑡
  
where µ is the net specific growth rate (h-1), Cx(t) and Cx(0) are the cell numbers at the end and 
start of the exponential growth phase, respectively and t is time (h).  
2. Population Doublings 
𝑃𝑃𝑔𝑔𝑆𝑆𝑃𝑃𝑃𝑃𝑟𝑟𝑔𝑔𝑆𝑆𝑔𝑔𝑃𝑃 𝐷𝐷𝑔𝑔𝑃𝑃𝐷𝐷𝑃𝑃𝑆𝑆𝑃𝑃𝑔𝑔𝐷𝐷,𝑃𝑃𝑑𝑑 = 1log  (2) ∙ log �𝐶𝐶𝑥𝑥(𝑡𝑡)𝐶𝐶𝑥𝑥(0)�  
where Pd is the number of population doublings, Cx(t) and Cx(0) are the cell numbers at the end 
and start of the exponential growth phase, respectively. 
3. Specific Metabolite Consumption/Production Rate 
𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆 𝑚𝑚𝑆𝑆𝑔𝑔𝑟𝑟𝐷𝐷𝑔𝑔𝑃𝑃𝑆𝑆𝑔𝑔𝑆𝑆 𝑆𝑆𝑃𝑃𝑃𝑃𝑓𝑓, 𝑞𝑞𝑚𝑚𝑚𝑚𝑡𝑡 = � 𝜇𝜇𝐶𝐶𝑥𝑥(0)� ∙ �𝐶𝐶𝑚𝑚𝑚𝑚𝑚𝑚(𝑡𝑡)−𝐶𝐶𝑚𝑚𝑚𝑚𝑚𝑚(0)𝑚𝑚𝜇𝜇𝑚𝑚−1 �  
where qmet is the net specific metabolite consumption or production rate, µ is the specific growth 
rate (h-1), Cx(0) is the cell number at the end of the exponential growth phase, Cmet(t) and Cmet(0) 
are the metabolite concentrations at the end and start of the exponential growth phase, 
respectively and t is time (h).  
 
2.4 hMSC Characterisation 
Immunophenotype analysis was performed by multiparameter flow cytometry before and after the 
hMSC expansion process using a previously developed protocol (Chan et al. 2014). In brief, this 
involved the use of flow cytometry where harvested, single cells were suspended in growth 
medium and loaded onto a 96 well plate. The cells were stained with monoclonal antibodies 
against the positive hMSC markers, CD73, CD90 and CD105 and the negative markers, CD34 & 
HLA-DR (BD Biosciences, UK) in addition with the corresponding isotype controls (BD 
Biosciences, UK). The antibodies selected were those recommended by the International Society 
for Cellular Therapy (ISCT) for the characterisation of hMSCs (Dominici et al. 2006).  
 
The hMSC differentiation was induced using Prime-XVTM Differentiation SFM (Irvine Scientific, 
USA) as per manufacturer’s instructions. After 21 days, the differentiation media were removed, 
cells rinsed with PBS then fixed with 4% (v/v) PFA at room temperature. Adipocytes were stained 
with 1% (w/v) Oil Red O (Sigma-Aldrich, UK) in isopropanol at room temperature and rinsed with 
distilled water. Osteoblasts were incubated with 2.5% (v/v) silver nitrate (Sigma-Aldrich, UK) 
under ultraviolet light (30 minutes exposure), rinsed with distilled water and stained with fast violet 
solution (Sigma-Aldrich, UK) containing 4% (v/v) napthol AS-MX phosphate alkaline (Sigma-
Aldrich, UK) for 45 minutes at room temperature in the dark. Chondrocytes were stained with 1% 
(w/v) Alcian blue (Sigma-Aldrich, UK) in 0.1 M hydrochloric acid (Sigma-Aldrich, UK). After 30 
minutes incubation, cells were rinsed three times with 0.1 M HCl. After staining, differentiated 
cells were visualized under a light microscope (Nikon Eclipse TS-100, UK). 
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2.5 Tracking of bead-to-bead cell transfer:  
Bead-to-bead cell transfer was assessed by two methods: 1) by employing visually distinctive 
microcarriers in the same culture system (adding a visually distinctive microcarrier at a later stage 
of the culture) and 2) by fluorescently labelling cells with two different Cell TrackerTM dyes (Life 
Technologies, ThermoFisher Scientific, UK). The use of visually distinctive microcarriers provides 
an effective way of demonstrating bead-to-bead transfer. The cells were originally cultured on the 
Plastic P102-L microcarriers in agitated spinner flask conditions (as described above). After 3 
days of culture, the visually distinctive microcarriers (either the Hillex or Cytodex-1) were added at 
the same microcarrier concentration during a 50% medium exchange. The culture was 
continuously agitated throughout the addition of the second microcarrier type so that the 
microcarriers were never static. This procedure unequivocally demonstrated the transfer of cells 
from the Plastic P102-L microcarrier to the new microcarrier (either Hillex or Cytodex-1).  
 
For the fluorescent labelling, Cell TrackerTM Green CMFDA and Cell TrackerTM Red CM-DiI (Life 
Technologies, ThermoFisher Scientific, UK) were employed. Cell TrackerTM Green contains 
chloromethyl derivatives of fluorescein diacetate (CMFDA) and is nonfluorescent until cytosolic 
esterases cleave off the acetates, releasing a brightly fluorescent product. Unlike the Cell 
TrackerTM Green CMFDA, Cell TrackerTM Red CM-DiI is a lipophilic carbocyanine that 
incorporates a mildly thiol-reactive chloro-methyl substituent with affinity for the lipids present 
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inside the cell membrane. These reagents pass freely through cell membranes, but once inside 
the cell, are transformed into cell-impermeant reaction products.  
 
The Cell TrackerTM dyes were used according to the manufacturer’s instructions. Briefly, based on 
the average cell concentration obtained post-harvest, the volume of cell suspension required for 
each experiment to achieve a cell density of 10,000 cells/cm2 was calculated and split in equal 
volumes in two separate centrifuge tubes. Cell pellets were then obtained by centrifuging the cell 
suspensions at 200g for 5 minutes. Each cell pellet was then resuspended in a working solution 
of Cell TrackerTM Red CM-DiI (working concentration of 20 µM) and Cell TrackerTM Green 
CMFDA (working concentration of 20 µM), respectively, and incubated in the dark at 37ºC for 40 
minutes. After incubation, the Cell TrackerTM working solutions were removed by centrifugation 
and replaced with fresh pre-warmed growth medium. The fluorescently-labelled cells were then 
seeded at 10,000 cells/cm2 on the pre-conditioned microcarriers in spinner flasks. Combinations 
of two different microcarriers (Plastic and Cytodex-1) and two different fluorescent dyes were 
used for this study.  The labelled cells were allowed to attach and proliferate for 48 h in agitated 
conditions, in the dark, at 37ºC and 5% CO2. After 48 h in culture, the different microcarrier-
labelled cell suspensions were mixed in a 50:50 proportion and the culture was continued for an 
additional 2 days. The mixed microcarrier-labelled cell suspensions were then imaged on the epi-
fluorescence microscope mentioned above.  
2.6 Statistical analysis 
For comparison between the two data sets comparing the mean specific growth rates, statistical 
significance was determined by using the Student’s two-tailed t-test. Significance was determined 
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at p < 0.05 (*) or p < 0.01 (**). GraphPad Prism 6 (California, USA) was used for the statistical 
analysis 
  
3. Results and Discussion 
The aim of this work was to demonstrate, both quantitatively and qualitatively, the phenomenon of 
bead-to-bead transfer of hMSCs on microcarriers under different culture conditions including cells 
from three BM-hMSC donors and under different culture medium conditions, FBS, HPL and SFM. 
An additional aim was to investigate the potential for process intensification through cells-on-
beads inoculation, where 10% of near-confluent microcarriers were used to inoculate a fresh 
microcarrier culture. 
 
Cell-microcarrier contact in bead-to-bead hMSC transfer is very likely to be influenced by a 
combination of factors such as donor cell line, medium composition, attachment substrate (i.e. 
microcarriers) and the process itself. The process employed with respect to the feeding regime, 
surface area provided or agitation intensity was kept constant during this study using a protocol 
that had been thoroughly tested and optimised for the successful expansion of bone-marrow 
derived hMSCs in spinner flasks in different medium conditions (Heathman et al. 2015; Rafiq et 
al. 2016). To account for donor variability, hMSCs from three donors were employed for this 
study.  
 
3.1 Qualitative demonstration of bead-to-bead transfer 
To qualitatively demonstrate hMSC migration from one microcarrier to another, two different 
methods were employed. The first method made use of commercially available microcarriers with 
different visual properties, while the second method consisted of fluorescently-labelling cells, 
followed by tracking their movements in culture.  
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Prior work with multiple types of microcarriers in a microcarrier screening study (Rafiq et al. 2016) 
showed that BM-hMSCs would attach and grow on most of the microcarriers albeit with varying 
degrees of success on each. It was also found that certain microcarriers were visually distinctive 
compared to others, for example the Cytodex-1 microcarriers are translucent in comparison to the 
solid Plastic P102-L microcarriers, and the Hillex microcarriers absorb the phenol red present in 
the medium and therefore turn a dark red colour. To demonstrate the phenomenon of hMSC 
bead-to-bead transfer qualitatively, the BM-hMSCs were initially cultured exclusively on Plastic 
P102-L microcarriers for a period of 6 days, after which fresh Hillex microcarriers (Figure 1A-C) or 
fresh Cytodex-1 microcarriers (Figure 1D-F) were aseptically added to the culture without 
stopping agitation of the culture at any point.  
 
As is indicated by the arrows in the figures, it is evident that BM-MSCs were attached to both the 
Plastic P102-L microcarriers (solid white) and the Hillex (dark red) microcarriers (Figure 1A-C). 
Similarly, cells were  attached to the Plastic P102-L and Cytodex 1 (translucent white) 
microcarriers (Figure 1D-F). The BM-hMSCs were found to be growing on microcarriers of both 
types as either cell-microcarriers aggregates, as well as on individual Plastic P102-L, Hillex and 
Cytodex-1 microcarriers (Figure 1A-F). This observation is consistent with both the bridging and 
cell migration methods of bead-to-bead transfer noted by Leber and colleagues in their studies 
using an immortalised hMSC line (Leber et al. 2017). It is worth noting that following the addition 
of the second type of microcarrier to the culture vessel, at no point was the agitation stopped and 
NJS was maintained throughout. These findings therefore provide a qualitative demonstration of 
bead-to-bead transfer during a continuing culture, whereby hMSCs have attached and 
proliferated on ‘fresh’ microcarriers days after the addition to the culture. 
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To demonstrate that these were indeed viable cells attached to both types of microcarriers 
(Plastic P102-L and Hillex), samples were stained with calcein AM (viable stain, green) and 
ethidium homodimer (non-viable stain, red) and assessed under a fluorescent microscope (Figure 
2). It is evident that the cells which are attached to the microcarriers in phase contrast images are 
indeed viable cells given the extent of viability staining exhibited in Figures 2B and 2D. Similar 
findings were found with the Plastic P102-L and Cytodex-1 pairing and the results depicted in 
Figure 2 are representative of that combination of microcarriers too.   
  
To further demonstrate the bead-to-bead transfer qualitatively, the cells were fluorescently 
labelled with two different fluorescent dyes prior to inoculation on the microcarriers. These Cell 
Tracker™ dyes are virtually non-fluorescent until cytosolic esterases found only inside living cells 
cleave off the acetate moiety, releasing a brightly fluorescent product. Moreover, these reagents 
pass freely through cell membranes, but once inside the cell, are transformed into cell-
impermeant reaction products. Further, the fluorescent probes are inherited by the daughter cells 
and are not transferrable to adjacent cells in a population. As such, the Cell Tracker™ Red-
labelled cells were cultured initially only onto Plastic microcarriers (solid) and the Cell Tracker™ 
Green-labelled cells cultured initially only onto the Cytodex-1 microcarriers (transparent) for 2 
days. After combining the two different types of microcarriers, there was evidence that Cell 
Tracker™ Red-labelled cells have migrated from Plastic onto Cytodex-1 microcarriers (white 
arrows) and vice versa (yellow arrows) (Figure 3A-3D). Notably, the migrated cells exhibited a 
more rounded morphology than these adherent cells normally do. During mitosis, adherent cells 
undergo a cycle of detachment and re-attachment (Yamakita et al. 1999) so this could be 
indicating active cell growth on the ‘new’ microcarrier that the cell has migrated to or it could be 
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an indication that following detachment from another microcarrier during mitosis, the cell had not 
yet fully adhered at the time of imaging.  
3.2. Quantitative demonstration of bead-to-bead transfer 
To quantitatively demonstrate bead-to-bead transfer, BM-hMSC1 and BM-hMSC2 were grown for 
6 days on Plastic P102-L microcarriers in either FBS-based or SFM culture conditions (Figure 4, 
Culture 1), after which, 10% of the microcarriers (with cells attached) were seeded into a fresh 
culture vessel with 90% fresh Plastic P102-L microcarriers (Figure 4, Culture 2). Upon inoculation 
of the microcarriers with cells attached, the vessel was immediately agitated at NJS. This was 
repeated for a third time (Figure 4, Culture 3).  
 
With each consecutive culture, it is noteworthy that the initial lag phase is reduced and with each 
culture, the final cell density obtained by the end is greater than the previous. For FBS cultures, 
the final cell density was found to be ~1.6 x 105 ± 0.15 cells/mL obtained with Culture 1, 2.01 x 
105 ± 0.06 cells/mL in Culture 2 and ~2.15 x 105 ± 0.08 cells/mL obtained in Culture 3 for hBM-
MSC1 and a similar trend was found for hBM-MSC2 (Figure 4). For SFM cultures, the cell yield 
was higher in all cases, but the same trend of reduced lag phase and increasing yield within the 
same time period (6 days) was noted. Moreover, in all cases, viability was > 95%, indicating 
favourable culture conditions in the vessel for the growth of hMSCs throughout the course of each 
culture. These findings indicate that a 10% concentration of near-to-confluent microcarriers was 
not only sufficient to inoculate a new vessel containing 90% fresh microcarriers, but decreased 
the lag phase of the new culture and increased the overall yield.  
 
The findings would appear to demonstrate bead-to-bead transfer given the fact that a 10% 
microcarrier concentration (with cells attached) was able to successfully inoculate a culture vessel 
with fresh microcarriers, with the culture eventually reaching a point of near-confluency prior to 
termination of the culture. Similar findings were observed by Ohlson et al. (1994) and Wang and 
Ouyang (1999) for adherent CHO cells who performed similar inoculation studies with near-
confluent and fresh microcarriers. Moreover, Ohlson et al. (1994) also observed an increase in 
the overall cell yield and a reduced lag phase, similar to what was found in this study. In addition 
to investigating a 10% addition of near-confluent microcarriers to a culture containing fresh 
microcarriers, Ohlson et al. (1994) also investigated inoculating a 25% concentration of near-
confluent microcarriers to a fresh culture and found that this resulted in a further reduced lag 
phase and an even greater cell density than the 10% near-confluent microcarrier addition. 
Although a 25% concentration of near-confluent microcarriers were not investigated in our study, 
that earlier finding indicates that an important process development activity might be to establish 
the optimal concentration of near-confluent microcarriers to inoculate into fresh bioreactor 
systems. This analysis will undoubtedly be a trade-off between the number of bioreactors to be 
seeded and the desired culture growth kinetics (similar to splitting a near-confluent T-flasks into 
multiple T-flasks). In a separate study, Badenes et al. (2017) demonstrated bead-to-bead transfer 
with hIPSCs, where it was found that this technique facilitated an increase in viable cell number 
and a concomitant significant increase in fold expansion within a 15 day culture. 
 
To further quantitatively demonstrate the phenomenon of bead-to-bead transfer, a fluorescence 
microscopy-based manual cell counting technique was adopted to highlight the difference 
between two inoculation methods. One (the control) used the well-established technique of cells 
in free suspension and the other, used inoculation of an equivalent number of cells attached to 
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10% of the beads. With these two methods, one would expect there to be a distinct difference in 
how the distribution of the hMSC population across the microcarriers changed over the culture 
period. For the control method using cells in suspension, the expectation would be very few cells 
per microcarrier at the start of the culture and with time as the hMSCs proliferated, this cell 
distribution would shift to higher numbers of cells per microcarriers. With the inoculation via the 
bead-to-bead transfer method, the expectation would be that the cell distribution splits into two 
distinct populations at the start of the culture, one population with a lot of cells, being the 
microcarriers added with cells attached, and the other being empty microcarriers. As the hMSCs 
proliferate and bead-to-bead transfer occurs, one would expect these two populations to merge 
over the course of the growth phase, finally producing similar distributions at the end of the 
cultures.  
 
The data presented (Figure 5A) reflects the expected trends, particularly in the case of inoculating 
cells in suspension as is traditionally done (the control) where the number of cells per bead began 
with many beads without cells at day zero with 75% of beads with 1 to 5 cells on day 1. The 
maximum number of cells per bead steadily increased until eventually at day 5, the maximum 
number of beads were those approaching or at confluence with between 5 to 15 cells per bead on 
the remainder.  
 
With the inoculation via cells on beads followed by bead-to-bead transfer (Figure 5B), few beads 
have many cells (some approaching confluence) and the remainder have none on day 0.  With 
the passage of time up to day 5, fewer and fewer beads are without cells and the number of cells 
is approximately the same on the other beads and steadily increases. At the end (day 5), a very 
high proportion of the beads are approaching or have reached confluence.  
 
 
3.3 Comparison of inoculation techniques  
Having established that BM-hMSCs can transfer to freshly added microcarriers and that a 10% 
concentration of near-confluent microcarriers could act as a sufficient inoculum for a fresh culture, 
to further prove the efficacy of the new approach, it was decided to include cells from a third 
donor (BM-hMSC 3) to supplement the two used in the experiments establishing bead-to-bead 
transfer (BM-hMSC 1, BM-hMSC 2). Also a third culture medium (HPL-based) was included.  The 
results inoculating with these three donor cells on Plastic P102-L microcarriers and three different 
medium are summarised in Figure 6 (FBS-based), Figure 7 (SFM) and Figure 8 (HPL-based). 
The results are also compared to our previous approach of free suspension inoculation as control 
(Rafiq et al. (2016); Heathman et al. (2015)). Though the results differed between the different 
medium, the data were very similar for each donor cell. Thus, the data presented in Figures 6-9 
illustrate a typical result for any of the cells in that specific medium conditions.   
There was a significant improvement in performance between the two approaches in all culture 
medium conditions (FBS, HPL and SFM) throughout the course of the culture, resulting in a 
higher cell density at the end of the culture when utilising cells-on-beads inoculation. For the FBS-
based culture, the cell density was ~ 2.0 x 105 cells/mL compared to ~1.5 x 105 cells/mL 
respectively (Figure 6A) and for SFM, the final cell densities were ~4.6 x 105 cells/mL, compared 
to ~3.4 x 105 cells/mL respectively (Figure 7A). A similar trend was found for HPL, where the 
values were ~3.6 x 105 and ~3.0 x 105 cells/mL respectively (Figure 8A). This increase in cell 
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yield is associated with a reduced lag phase for all cultures using the cells-on-beads inoculation 
method, enabling the cells to reach the higher growth phase of the culture quicker in comparison 
to the control. This more rapid achievement of fast growth is illustrated in Figures 6-8B and 
Figures 6-8C.  Figures 6-8 B, shows that for FBS, SFM and HPL cultures, the cells’ mean specific 
growth rate was significantly higher between days 0-2 with the cells-on-beads inoculation when 
compared to the controls (Figures 6-8C).  After that, the growth rate for each method reached 
parity between days 2-4. These figures also make clear that there was a reduced lag phase with 
cells-on-beads inoculation. 
  
The specific glucose consumption rate along with the specific lactate and ammonia production 
rates were also calculated for each culture (Figure 9). For FBS-based culture, the specific 
glucose consumption rate during pre-culture for both the inoculation via cells-on-beads and the 
control method was ~19 pmol.cell-1.d-1. Then between days 0-2 post inoculation, these values 
sharply rose to ~38 pmol.cell-1.d-1 for the inoculation via cells-on-beads and was even higher (~45 
pmol.cell-1.d-1) for the control. Between days 2-4, the glucose consumption rates have settled 
back down to similar values of ~20 pmol.cell-1.d-1 for both methods. This increase in specific 
glucose consumption rate during the first 2 days of culture was mirrored by an increase in the 
specific lactate and ammonia production rates during the same time phase. A distinct trend could 
be seen across each medium type, where in general an increase in specific 
consumption/production rates over the first 2 days of culture was significantly reduced when 
using the inoculation via cells-on-beads instead of the control. It must be noted that all rates were 
significantly reduced when using a serum-free medium. 
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This trend suggested that using inoculation by cells-on-beads resulted in a reduced impact on the 
metabolic activity of the hMSCs during the early phase of culture that can likely be attributed to 
the production of extracellular components required for attachment when using the control 
method. Although it has not been explored here, this highlights a potential impact of multiple 
trypsinisation steps on the potency or long-term proliferative capability of hMSCs which could be 
avoided by adopting the inoculation via cells on beads followed by bead to bead transfer. 
 
With respect to characterisation, the BM-hMSCs, both pre-inoculation and post-harvest were 
characterised with respect to cell identity (immunophenotypic expression) and functionality 
(differentiation potential). In all cases (different culture medium conditions and inoculation 
methods), the BM-hMSCs were found to be in accordance with the ISCT criteria (Dominici et al. 
2006). Representative data is shown for the condition wherein the BM-hMSCs were cultured in 
SFM and inoculated using cells-on-beads. However similar findings were found for all other 
conditions (data not shown). The data demonstrates that there was > 95% co-expression of 
CD105, CD90 and CD73 and less than 2% positive for the negative markers CD34 and HLA-DR 
for the harvested BM-hMSCs (Supplementary Figure 1). Moreover, the cells were analysed for 
the retention of their tri-lineage differentiation potential towards the osteogenic, chondrogenic and 
adipogenic pathways. Again, in all cases, the BM-hMSCs were found to retain their differentiation 
potential (Supplementary Figure 1).  
The impact of this study is particularly relevant to the production phase for hMSC manufacture, 
where the need for large numbers of cells within a limited time period may be necessary. This 
approach allows for multiple bioreactors to be inoculated and operated in parallel from a small 
percentage of near-confluent microcarriers, which lends itself well to an allogeneic cell therapy. 
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This production approach is akin to T-flask based culture, where a near-confluent T-flask is ‘split’ 
into other T-flasks to facilitate the progression of culture. The  new approach offers a significant 
advantage in that the scale of a stirred-tank bioreactor is significantly larger than that of a T-flask 
and therefore so is the yield of cells that can be obtained. Combined with the ability to increase 
surface area during the course of the culture through the addition of fresh microcarriers, this 
approach facilitates significant expansion potential. Unlike a traditional seed train process from 
primary cells, this process could enable cells to be cultured at relatively low population doublings 
in multiple reactors before either being frozen down as a part of a master/working cell bank, or 
indeed, for the final manufacture of cells. 
  
4. Conclusions 
Bead-to-bead transfer is widely believed to occur in anchorage-dependent microcarrier cultures. 
Unlike previous studies investigating this phenomenon, this study describes the approach taken 
to demonstrate bead-to-bead transfer, both qualitatively and quantitatively, for three different BM-
hMSC donors and under different culture medium conditions, FBS, HPL and SFM. Qualitative 
demonstration of the phenomenon was achieved by using microcarriers with distinctive visual 
properties and cell-tracking fluorescent reagents where it was demonstrated that freshly added 
microcarriers to an existing culture were soon populated by BM-hMSCs, with examples of cells 
bridging between different microcarriers, and in other instances cells attaching and proliferating 
on the freshly added microcarriers in isolation. Quantitative demonstration of the phenomenon 
was established by the process of taking 10% of near-confluent microcarriers to inoculate a fresh 
microcarrier culture (cells-on-beads inoculation), where it was found that bead-to-bead transfer 
not only occurred, but that this inoculation method, in contrast to the control (where cells were 
inoculated via free suspension), increased cell growth rate and overall cell yield. The increase in 
cell yield was associated with a reduced lag phase for all cultures using the cells-on-beads 
inoculation method, enabling the cells to reach the higher growth phase of the culture quicker in 
comparison to the control. It was also demonstrated that the cell identity and differentiation 
potential was retained in all culture medium conditions and with both inoculation methods. Cells-
on-beads inoculation is clearly an effective means of process intensification and can have a 
significant impact on reducing overall expansion times and therefore the costs of BM-hMSC and 
other anchorage-dependent cell therapies.  
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Figure captions 
Figure 1: Phase contrast images of the bead-to-bead transfer between the different types of 
microcarriers, Plastic (white with black rim), Hillex (red) and Cytodex-1 (translucent white). The 
white arrows indicate cell-microcarrier aggregates between two different microcarriers. The black 
arrows indicate single cells attached to a specific microcarrier. Representative images from BM-
hMSC1 (A, B, E, F), BM-hMSC2 (C, D, G, H) are illustrated. Figures were taken at day 6 after 
inoculation (3 days after adding the second type of microcarrier).  
Figure 2: Phase contrast (A; C) and Live/Dead staining (B; D) images of the same microcarriers 
and cells demonstrating the bead-to-bead transfer. Representative images from BM-hMSC1 (A,B) 
and BM-hMSC2 (C,D) are depicted with similar findings across both donors used. Figures were 
taken at day 6 after inoculation (3 days after adding the second type of microcarrier). The 
microcarriers used were Plastic (white with black rim) and Hillex (red). 
Figure 3: Fluorescent and bright field images showing Cell Tracker Red-labelled cells migrated 
from Plastic (solid) to Cytodex-1 (transparent) microcarriers (white arrows) and Cell Tracker 
Green-labelled cells migrated from Cytodex-1 to Plastic microcarriers (yellow arrows). (A) Bright 
field image; (B) Cell Tracker-Green; (C) Cell Tracker-Red; (D) Merged. Scale bar represents 100 
µm.  
Figure 4: Quantitative demonstration of bead-to-bead culture in FBS and SFM cultures with BM-
hMSC1 and BM-hMSC2 donor cells cultured on Plastic P102-L microcarriers. Data show mean ± 
SD, n = 3. 
Figure 5: Cell distribution on microcarriers when using (A) the standard cell inoculation method or 
(B) the cells-on-beads inoculation method. The gradiation in colour (from light to dark) represents 
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the numbers of cells on microcarriers. Data represents BM-hMSC3 cells cultured on Plastic P102-
L microcarriers in HPL. The data is representative of findings from the other donor cells and 
cultured in the other medium compositions. 
Figure 6: Comparison of BM-hMSC1 growth on Plastic P102-L microcarriers in a FBS-containing 
medium when using the standard cell inoculation (control) or cells-on-beads inoculation, where 
the data represents, (A) the cell density (cells/mL) over 7 days, (B) the mean specific growth rate 
(d-1) over the course of the culture and (C) a logarithmic plot of the cell density across the culture 
period. Data show mean ± SD, n = 3. Significance was determined at p < 0.05 (*) or at p < 0.01 
(**).  
Figure 7: Comparison of BM-hMSC2 growth on Plastic P102-L microcarriers in the SFM when 
using the standard cell inoculation (control) or cells-on-beads inoculation, where the data 
represents, (A) the cell density (cells/mL) over 7 days, (B) the mean specific growth rate (d-1) over 
the course of the culture and (C) a logarithmic plot of the cell density across the culture period. 
Data show mean ± SD, n = 3. Significance was determined at p < 0.05 (*) or at p < 0.01 (**). 
Figure 8: Comparison of BM-hMSC3 growth on Plastic P102-L microcarriers in a HPL-containing 
medium when using the standard cell inoculation (control) or cells-on-beads inoculation, where 
the data represents, (A) the cell density (cells/mL) over 7 days, (B) the mean specific growth rate 
(d-1) over the course of the culture and (C) a logarithmic plot of the cell density across the culture 
period. Data show mean ± SD, n = 3. Significance was determined at p < 0.05 (*) or at p < 0.01 
(**). 
Figure 9: Metabolite data for the cultures comparing the standard cell inoculation (control) and 
cells-on-beads inoculation across the different culture medium conditions, FBS, HPL and SFM. 
(A-C) represents the mean specific glucose consumption rate (pmol.cell-1.d-1), the mean specific 
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lactate production rate (pmol.cell-1.d-1) and the mean specific ammonia production rate (pmol.cell-
1.d-1) for the FBS culture. (D-F) represents the mean specific glucose consumption rate (pmol.cell-
1.d-1), the mean specific lactate production rate (pmol.cell-1.d-1) and the mean specific ammonia 
production rate (pmol.cell-1.mL-1) for the HPL culture. (G-I) represents the mean specific glucose 
consumption rate (pmol.cell-1.mL-1), the mean specific lactate production rate (pmol.cell-1.d-1) and 
the mean specific ammonia production rate (pmol.cell-1.d-1) for the SFM culture. Data show mean 
± SD, n = 3. 
Supplementary Figure 1: Immunophenotypic expression for BM-hMSC1 (A) and differentiation of 
the BM-hMSC1 toward the (B) adipogenic, (C) osteogenic and (D) chondrogenic lineages. All 
data are of cells cultured on Plastic P102-L microcarriers. Representative data was obtained for 
all other cell donors and in all other medium conditions. 
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